Search

Author/Creator Mathurin, Tammy

1. 167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy. (October 2019)

Authors:
Mekhaeil, Bassem; Zacharidis, Panagiotis; Tsakiridis, Evelyn; Biziotis, Olga-Demetra; Broadfield, Lindsay; Menjolian, Gabe; Mathurin, Tammy; Farrell, Thomas; Muti, Paola; Liu, Stanley; Steinberg, Gregory; Tsakiridis, Theodoros
Journal:
Radiotherapy and oncology
Issue:
Volume 139(2019)Supplement 1
Page Start:
S71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy. (October 2019)

Authors:
Biziotis, Olga-Demetra; Tsakiridis, Evangelia - Evelyn; Broadfield, Lindsay; Farrell, Thomas; Menjolian, Gabe; Mathurin, Tammy; Mekhaeil, Bassem; Zacharidis, Panagiotis; Muti, Paola; Abdulkarim, Bassam; Steinberg, Gregory; Tsakiridis, Theodoros
Journal:
Radiotherapy and oncology
Issue:
Volume 139(2019)Supplement 1
Page Start:
S20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Salicylate enhances the response of prostate cancer to radiotherapy. Issue 5 (4th January 2019)

Authors:
Broadfield, Lindsay A.; Marcinko, Katarina; Tsakiridis, Evangelia; Zacharidis, Panayiotis G.; Villani, Linda; Lally, James S. V.; Menjolian, Gabe; Maharaj, Danitra; Mathurin, Tammy; Smoke, Marcia; Farrell, Thomas; Muti, Paola; Steinberg, Gregory R.; Tsakiridis, Theodoros
Journal:
Prostate
Issue:
Volume 79:Issue 5(2019)
Page Start:
489
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search